About Us

Thermogram Clinic by MRL is the midwest’s premier breast thermogram facility that is dedicated to breast tissue health education our partnering practitioners understand the benefits of thermography, and understand that thermograms are part of a breast tissue wellness program.

Thermography was approved in 1982 by the FDA for use as adjunct testing screening procedures in the diagnosis, quantifying, and screening of differences in skin surface temperature changes. X-Rays, mammography, ultrasound, and MRIs are all tests that provide information on the structures found within the body. Thermography is an imaging technology that can visualize and document temperature pattern variations showing physiological changes. By enabling practitioners to monitor the effects of treatments and lifestyle changes, thermography allows practitioners to make adjustments to treatment protocols, thus allowing earlier interventions in breast tissue health programs.

Further, all thermograms are interpreted and reviewed by Dr. Robert Kane “The Voice of Thermography,” who brings decades of experience as he reviews thermograms for most reputable thermographers including others in this area.

Breast thermography services offered by MRL remind clients of how imperative the addition of a qualified practitioner is to ones breast tissue health program. We have teamed up with midwest thermography experts to review your thermogram results with. Our team we have partnered with consisted of holistic nurses, medical doctors, chiropractors and many more.
The use of thermal imaging in health care is not a recent phenomenon. Its utilization in breast tissue health screening, however, is seeing renewed interest. This attention is fueled by research that clearly demonstrates the value of this procedure and the tremendous impact it can have on the mortality of breast tissue abnormalities.

The following is not a comprehensive review of the literature. Over 30 years of research compiling over 800 studies in the index-medicus exist. What follows is a pertinent summary of the research concerning the clinical application of diagnostic infrared imaging (thermography) for use in breast cancer screening. All the information is taken from the index-medicus peer-reviewed research literature or medical textbooks.

  • In 1982, the FDA approved breast thermography as an adjunctive diagnostic breast cancer screening procedure.
  • Breast thermography has undergone extensive research since the late 1950’s.
  • Over 800 peer-reviewed studies on breast thermography exist in the index-medicus literature.
  • In this database, well over 300,000 women have been included as study participants.
  • The numbers of participants in many studies are very large – 37K, 60K, 85K …..
  • Some of these studies have followed patients up to 12 years.
  • Strict standardized image interpretation protocols have been established for over 15 years.
  • Breast thermography has an average sensitivity and specificity of 90%.
  • An abnormal thermogram is 10 times more significant as a future risk indicator for breast cancer than a first order family history of the disease.
  • A persistent abnormal thermogram is at a 22x higher risk of future breast cancer.
  • An abnormal infrared image is one of the important markers of high risk for developing breast tissue health.
  • Breast thermography has shown the ability to detect some of the first signs that breast tissue health may be detreating up to 10 years before any other procedure can detect it.
  • Extensive clinical trials have shown that breast thermography significantly augments the long-term survival rates of its recipients by as much as 61%.
  • When used as part of a multimodal approach (clinical examination + mammography + thermography) 95% of early stage of breast tissue health deterioration will be detected.

Note: Breast thermography offers women information that no other procedure can provide. However, breast thermography is not a replacement for or alternative to mammography or any other form of breast imaging. Breast thermography is a risk assessment tool that is meant to be used in addition to mammography and other tests or procedures. Breast thermography and mammography are complementary procedures, one test does not replace the other. All thermography reports are meant to identify thermal emissions that suggest potential risk markers only and do not in any way suggest diagnosis and/or treatment. Studies show that the earliest detection is realized when multiple tests are used together. This multimodal approach includes breast self-examinations, physical breast exams by a doctor, mammography, ultrasound, MRI, thermography, and other tests that may be ordered by your doctor.